ASCO 2024: New study details longest progression-free survival ever reported in advanced NSCLC
For patients with previously untreated, advanced non-small cell lung cancer (NSCLC) with an anaplastic lymphoma…
Browsing: ASCO
ASCO 2024: Prostate cancer spit test better for men with high genetic risk than standard blood test
A spit test, where a sample can be collected at home, is more accurate at…
ASCO 2024: Novel therapy combination more effective at treating Hodgkin lymphoma than established treatment
A new study showed that BrECADD, a novel therapy combination, cured classic Hodgkin lymphoma more…
ASCO 2024: Shorter durations of venetoclax yields similar response rates in AML
When combined with azacitidine, a 7-day course of venetoclax demonstrated similar remission rates and was…
ASCO 2024: Adding belantamab mafodotin to multiple myeloma treatment combinations slows disease progression or death
According to a new study, adding belantamab mafodotin to pomalidomide and dexamethasone for the treatment…
ASCO 2024: Risk reduction from HPV vaccination goes beyond cervical cancer
Results from a new study suggest that the human papillomavirus (HPV) vaccine is effective in…
ASCO 2024: Artificial intelligence-based patient navigator may help improve disparities in colon cancer screening
An artificial intelligence-based patient navigator tool demonstrated improved potential in helping to overcome patient attrition…
ASCO 2024: Asciminib may be safer, more effective treatment option for patients with newly diagnosed chronic myeloid leukaemia
A new study found asciminib to be a potentially safer and more effective treatment option…
ASCO 2024: Oestrogen-only hormone therapy may increase cancer risk while oestrogen-progestin combination may lower risk
For people who have been through menopause and have taken menopausal hormone therapy, conjugated equine…
ASCO 2024: Combination therapy significantly improves outcomes for patients with metastatic colorectal cancer
A study led by UCLA Health Jonsson Comprehensive Cancer Center researchers found that using a combination of experimental immunotherapy drugs…